Search results for "HIV"


 
Results 31 - 40 of about 289 for "HIV".
Sort by: Relevance | Newest | Oldest

Details on second mRNA COVID-19 vaccine boosters

This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/05/details-on-second-mrna-covid-19-vaccine-boosters.htm
1 May 2022

MKSAP Quiz: Difficulty swallowing for 6 months

A 54-year-old man is evaluated for difficulty swallowing of 6 months' duration. He initially had occasional choking with liquids, which has progressed to dysphagia with both liquids and solids. Following a physical exam, lab tests, and MRI of the brain, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2022/03/15/3.htm
15 Mar 2022

New data on COVID-19 vaccines' effectiveness against omicron, among immunocompromised

One English analysis showed how COVID-19 boosters increase protection against symptomatic infection from omicron, while two studies looked at vaccinating the immunocompromised, and ACP videos worked to educate patients and increase vaccine uptake.
https://immattersacp.org/weekly/archives/2022/03/08/2.htm
8 Mar 2022

MKSAP Quiz: Follow-up for gonococcal arthritis

A 23-year-old woman undergoes follow-up after treatment for gonococcal arthritis. Following a physical exam, what is the most appropriate screening test to perform next?
https://immattersacp.org/weekly/archives/2022/03/01/3.htm
1 Mar 2022

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/03/latest-updates-on-acps-priorities-initiatives.htm
1 Mar 2022

Details on COVID-19 treatments authorized for outpatients

This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/03/details-on-covid-19-treatments-authorized-for-outpatients.htm
1 Mar 2022

Long-acting injectable cabotegravir not cost-effective for HIV PrEP

While the long-acting injectable form of cabotegravir has shown superior effectiveness for HIV pre-exposure prophylaxis (PrEP), a cost-effectiveness analysis found that the drug is too expensive at its current price compared to the daily oral medication available as a generic.
https://immattersacp.org/weekly/archives/2022/02/01/5.htm
1 Feb 2022

New research on mixed vaccine boosters, long-term outcomes, omicron severity

A study found mixing and matching of COVID-19 vaccines to be safe and effective, other research showed ongoing symptoms to be common at one year after infection, the CDC analyzed the severity of omicron, and the FDA revised outpatient treatment authorizations.
https://immattersacp.org/weekly/archives/2022/02/01/1.htm
1 Feb 2022

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/02/latest-updates-on-acps-priorities-initiatives.htm
1 Feb 2022

‘Best of Annals 2021’ collection and video now available

The editors of Annals of Internal Medicine have curated a list of some of the most influential articles published by the journal over the past year.
https://immattersacp.org/weekly/archives/2022/01/18/5.htm
18 Jan 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next